GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

American Green ERBB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.5m

FY2016FY2025

Net income

$9.6m

FY2016FY2025

Free cash flow

—

FY2016FY2025

Shareholders' equity

−$10.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.5m$1.7m$3.8m$2.2m$2.4m$1.8m$1.3m$189,737$39,335$378,884
Operating income−$66,845−$590,583−$471,015−$1.2m−$891,720−$705,240−$1.2m−$1.7m−$1.4m−$1.8m
Net income$9.6m−$5.4m−$2.5m−$2.6m−$651,511−$4.7m−$3.0m−$3.7m−$1.9m−$2.7m
Diluted earnings per share0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.08-0.05-0.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$352,674$359,519$9.7m$10.1m$4.8m$5.0m$11.3m$11.4m$2.5m$2.3m
Cash and short-term investments$2,155$934$14,181$47,268$167,641$81,918$12,641$288,088$315,871$12,787
Total liabilities$10.7m$20.3m$24.3m$22.4m$15.1m$16.1m$18.9m$18.1m$9.4m$9.7m
Debt$10.1m$19.8m$23.3m$17.7m$11.9m$12.3m$15.5m$16.1m$8.8m$9.1m
Shareholders' equity−$10.3m−$20.0m−$14.6m−$12.3m−$10.3m−$11.1m−$8.3m−$6.7m−$6.9m−$7.4m
Shares outstanding4,342m4,282m4,282m3,891m3,665m4,342m4,342m44m38m23m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations——$56,780−$831,458$1.1m$279,553$113,846$612,194−$1.7m−$1.9m
Capital spending——−$260,887−$5.8m—−$71,881−$556,077−$9.0m−$484,328—
Free cash flow——−$204,107−$6.7m$1.1m$207,672−$442,231−$8.4m−$2.2m−$1.9m

Latest quarters

By quarter end

Sept 2025Sept 2024Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022
Revenue$315,596—$483,695$722,099$1.1m$1.0m$1.0m$639,342
Operating income−$100,198−$10,293−$165,211−$80,370−$179,910−$190,850−$19,880−$158,650
Net income−$172,527−$322,912−$3.0m−$821,778−$553,468−$649,516−$477,010−$927,493
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Capital spending———————−$3.0m
Total assets$561,620$363,585$4.3m$9.7m$10.2m$10.3m$10.2m$10.1m
Cash and short-term investments$1,000$5,000$22,098$14,181$55,225$154,156$67,048$47,268
Debt$10.2m$20.1m$20.4m$22.8m$22.5m$22.2m$18.0m$17.3m
Shareholders' equity−$10.5m−$20.3m−$17.6m−$14.6m−$13.8m−$13.4m−$12.8m−$12.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-12.9%-4.0%8.9%
Operating income-62.1%-37.6%-31.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-20.9%-25.7%-29.6%-81.8%
Net margin135.9%-9.5%-46.3%-165.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings0.1-0.2-0.0-0.0-0.4-0.1-0.3-0.0-0.1-0.0
Price to sales0.90.60.00.10.10.30.70.12.90.1

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-17%1900%-46%-50%-23%-69%-60%-69%16%-10%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 500-to-1 reverse split · 23 Sept 2019
  • 1000-to-1 reverse split · 25 Jun 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.